Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kyoko Shikichi"'
Autor:
Masakazu Ozaki, Toshihiko Kobayashi, Aki Fujinaga, Mitsuaki Nishioka, Kyoko Shikichi, Satoshi Okano, Yasuhito Sakai, Sayumi Fujii, Nobuaki Matsui, Miwako Takasago, Naoto Okada, Takahiro Yamasaki, Takashi Kitahara
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Pharmaceutical companies do not sell formulations for all diseases; thus, healthcare workers have to treat some diseases by concocting in-hospital preparations. An example is the high-concentration 2% cyclosporine A (CyA) ophthalm
Externí odkaz:
https://doaj.org/article/aa4113ea04394a03abef6823a5f962e2
Autor:
Chieko Hino, Masakazu Ozaki, Takashi Kitahara, Kyoji Kouda, Kyoko Shikichi, Itaru Nakamura, Shinya Kawai, Shigeharu Oie
Publikováno v:
International Journal of Medical Sciences. 20:566-571
Autor:
Shigeharu Oie, Kyoko Shikichi
Publikováno v:
Japanese Journal of Infection Prevention and Control. 36:72-74
Autor:
Toshihiko Kobayashi, Akira Kamiya, Kyoko Shikichi, Youko Kobayashi, Shiro Ishida, Hidekazu Mizuno, Shigeharu Oie, Kumiko Maeda, Yoshiro Okano
Publikováno v:
Biological and Pharmaceutical Bulletin. 31:1898-1901
We evaluated the effects of antimicrobial drugs on four strains of Pseudomonas aeruginosa that are resistant to eight widely used antipseudomonal drugs (piperacillin, piperacillin-tazobactam, imipenem, meropenem, ceftazidime, aztreonam, amikacin, cip
Publikováno v:
International Journal of Cancer. 103:97-100
MUC1 is immunogenic in vivo and humoral and cellular immune responses against MUC1 have been detected in cancer patients. Our study explored the association of circulating anti-MUC1 antibodies with clinicopathological parameters or patients' survival